HPV Frequency and Protection Behavior of Women with HPV Screening Between 30-65 Years in a Primary Health Care Center
Abstract
Objective : Although cervical cancer is common, because of the presence of pre-invasive lesions and due to the fact that the cervix is an easily accessible organ, it is an appropriate disease for early diagnosis, prevention, treatment and even eradication.
We aimed to evaluate the results of HPV-DNA screening program in women between the ages of 30-65 in a primary care setting and to make recommendations for preventable risk factors.
Method: In this cross-sectional descriptive study we evaluated the records of 716 women 30-65 years old who scanned for HPV between 2014-2016 in a primary health care center. In the evaluation of data obtained, descriptive statistical methods and chi square test were used.
Results: The average age of women included in the study was 44,11 ± 9,25, 97.1% were married; the age of first sexual intercourse was minimum 13 maximum 34 (mean 19,76 ± 3,67). Of women 20,81% smoked in various amounts, and 26,68% of them used hormonal contraceptives for varying periods of time. HPV-DNA (+) was found in 19 (2.65%) of the women. Of these, 7 (1%) were HPV-16.
Conclusion: In our study, however the positive rate of HPV-DNA is lower than the studies done in Turkey and abroad, the high-risk HPV genotype-16 ratio was higher. We concluded that HPV vaccination, condom use and regular gynecological examination rates are inadequate in women which we included in our study and this may be due to economic reasons as well as socio-cultural factors.
Keywords
References
- (1) Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424.
- (2) Jaime Prat, Silvia Franceschi. Cancers of the female reproductive organs. In: World cancer report 2014 (ed) Bernard W. Stewart and Christopher P. Wild . International Agency for Research on Cancer, 2014; Lyon pp: 465-81
- (3) Turgay AS, Khorshid L, Eser I. Effect of the first chemotherapy course on the quality of life cancer patients in Turkey. Cancer Nursing 2008;31:1-5.
- (4) Xavier Castellsague´, Nubia Munoz. Cofactors in Human Papilloma virus Carcinogenesis Role of Parity, Oral Contraceptives, and Tobacco Smoking. J. Natl. Cancer Inst. Monogr. 2003; 31:20-8
- (5) Gierisch J.M. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomarkers Prev.2013; 22(11):1931-43.
- (6) Muñoz N, Franceschi S, Bosetti C, et al. Role of parity and human papilloma virus in cervical cancer: the IARC multicentric case-control study. Lancet 2002; 359(9312)1093-101.
- (7) Andrae, B, Kemetli L, Sparén P, et al. Screening-preventable cervical cancer risks: evidence from a nation wide audit in Sweden. J Natl Cancer Inst. 2008; 100(9): p. 622-9.
- (8) Munoz, N., et al. Epidemiologic classification of human papilloma virus types associated with cervical cancer. N Engl J Med. 2003; 348(6): p. 518-27
Details
Primary Language
English
Subjects
Health Care Administration
Journal Section
Research Article
Authors
Sümeyra Gürgen
This is me
0000-0003-1887-2512
Türkiye
Cenk Aypak
0000-0002-8381-790X
Türkiye
Publication Date
March 2, 2020
Submission Date
April 10, 2019
Acceptance Date
October 7, 2019
Published in Issue
Year 2020 Volume: 12 Number: 1


